HSP induces apoptosis in a dose-dependent manner by decreasing Bcl-2 and increasing Bax protein expression and causes cell cycle arrest by reducing cyclin B1, CDK1 and increasing tumour suppressor gene p21 phosphorylation p38 MAPK, arresting the G2/M phase [12]. The gene discussed is BCL2; the disease is hereditary spastic paraplegia.